CME, a maker of infusion and syringe pumps, will operate independently but CareFusion will now have the right to make itself a minority shareholder, as part of a strategic, long-term relationship.
CareFusion plans to complete the transaction by the end of March.
More Articles on Supply Chain:
Philadelphia Pediatric Device Consortium Receives $1.5M in FDA Funding
Global Medical Automation Market to Reach $66.92B by 2018
Evergreen Medical, Bose Partner to Enhance Medical Device Testing Capabilities
